WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004096204) LACTATE CONTAINING PHARMACEUTICAL COMPOSITION AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/096204    International Application No.:    PCT/SG2004/000066
Publication Date: 11.11.2004 International Filing Date: 22.03.2004
Chapter 2 Demand Filed:    17.01.2005    
IPC:
A23L 1/304 (2006.01), A61K 31/19 (2006.01), A61K 33/00 (2006.01)
Applicants: INNOGENE KALBIOTECH PTE LTD [SG/SG]; 18 Cross Street, #07-06 Marsh & McLennan Centre, Singapore 048423 (SG) (For All Designated States Except US).
LEVERVE, Xavier, M. [FR/FR]; (FR) (For US Only).
IQBAL, Mustafa [IN/IN]; (IN) (For US Only)
Inventors: LEVERVE, Xavier, M.; (FR).
IQBAL, Mustafa; (IN)
Agent: RAVINDRAN, Muthucumarasamy; Ravindran Associates, 61 Stamford Road, #02-09 Stamford Court, Singapore 178892 (SG).
SCHIWECK, Wolfram, D.; Viering, Jentschura & Partner, 210 Middle Road, #09-07/08 IOI Plaza, Singapore 188994 (SG)
Priority Data:
P00200300213 01.05.2003 ID
Title (EN) LACTATE CONTAINING PHARMACEUTICAL COMPOSITION AND USES THEREOF
(FR) COMPOSITION PHARMACEUTIQUE A TENEUR EN LACTATE ET UTILISATIONS DE LADITE COMPOSITION
Abstract: front page image
(EN)The invention relates to a pharmaceutical composition containing 250 to 2400 millimoles per liter of lactate or lactic acid, 2 to 10 millimoles per liter of potassium cation and optionally 2 to 5 millimoles per liter of calcium cation. The invention also relates to pharmaceutical uses of this composition. The invention also relates to pharmaceutical uses of a composition having a lactic acid or lactate concentration between 250 to 2400 millimoles per liter.
(FR)L'invention concerne une composition pharmaceutique contenant 250 à 2 400 millimoles par litre de lactate ou d'acide lactique, 2 à 10 millimoles par litre de cation potassium et éventuellement 2 à 5 millimoles par litre de cation calcium. Ladite invention concerne également des utilisations pharmaceutiques de cette composition ainsi que des utilisations pharmaceutiques d'une composition présentant une concentration de lactate ou d'acide lactique comprise entre 250 et 2 400 millimoles par litre.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)